English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Healthy Hearing
+
Community
Patient Daily
| Mar 21, 2026
Pros and cons of rechargeable hearing aids discussed by experts
+
Community
Patient Daily
| Mar 15, 2026
Experts discuss how hearing loss can affect romantic relationships and communication
+
Community
Patient Daily
| Mar 15, 2026
Traumatic brain injury can cause a range of hearing problems
+
Community
Patient Daily
| Mar 6, 2026
Oticon launches Zeal: an AI-powered in-the-ear hearing aid with flexible fitting
+
Community
Patient Daily
| Feb 21, 2026
Older adults increasingly consider cochlear implants for severe hearing loss
+
Community
Patient Daily
| Feb 5, 2026
Tips offered for adjusting to new hearing aids
+
Community
Patient Daily
| Jan 22, 2026
Personal story highlights potential relief methods for managing chronic tinnitus
+
Community
Patient Daily
| Jan 17, 2026
Invisible hearing aids offer discreet solution for mild to moderate hearing loss
Trending
+
Pharmaceuticals
Patient Daily
| Aug 4, 2026
Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+
Pharmaceuticals
Patient Daily
| Aug 6, 2026
FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+
Regulatory
M. Y. Bailey
| Aug 7, 2026
PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
+
Regulatory
M. R. Armstrong
| Aug 4, 2026
Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
1
2
»
Last »